InvestorsHub Logo
Followers 230
Posts 14737
Boards Moderated 1
Alias Born 03/29/2014

Re: marzan post# 74135

Saturday, 09/17/2016 1:48:31 PM

Saturday, September 17, 2016 1:48:31 PM

Post# of 705591
Those are some amazing case studies Marzan. Be careful that Dr. Buzdar doesn't read those because those reported yet unconfirmed responses may give some patients "a rosy picture." He tends to get upset when immunotherapy works as he is a big advocate of chemotherapy.

https://www.thestreet.com/story/12749366/2/prestigious-cancer-hospital-rebukes-northwest-bio-for-inappropriate-data-disclosures.html

Remember this?

"The weakness of this approach is that there have been many studies in which tumors are injected locally -- the injections could consist of anything (think Adam suggested grapefruit juice?) -- and you see tumor regression because of necrosis caused by inflammation," said Buzdar. "But it is a tremendous leap to say that this is a real response, which is why what the company is saying is so inappropriate." - Dr. Aman Buzdar



I think that it's been confirmed now that in immunotherapy, this swelling constitutes a "real response" so at least that should give Dr. Buzdar some piece of mind.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News